Not at all. Our primary audience is actually the sleep partners of those who snore! They are often the ones’ who suffer from the effects of snoring most. They may also be the ones most concerned by the pauses in breathing they witness when they are awake.

About 90 million individuals in the U.S. snore and it is estimated that over half of them may suffer from undiagnosed Obstructive Sleep Apnea (OSA). Use of the RestBud™ by these individuals may potentially prevent the onset of illnesses caused by decades of undiagnosed pauses in breathing. Restigram™ Personal Sleep Reports™ developed by the RestBud™ may also encourage undiagnosed OSA patients to seek further medical treatment.